Lysosomal acid lipase deficiency (LAL-D) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 10.00% and is expected to reach USD 1,271.49 million by 2028 in the above-mentioned research forecast period. Increase dependency on enzyme replacement therapy and presence of large untreated patient population.
Continued use of supportive care therapies and developing biotechnology and pharmaceutical sector also boost up the market growth. Moreover, increasing partnership and collaboration among market players and high unmet patient needs act as opportunity for the market growth. But, lack of disease awareness, high treatment cost and strict regulations may hamper the global Reye syndrome treatment market.
Lysosomal acid lipase deficiency syndrome is an autosomal recessive storage disease characterized by mutation in LIPA gene. LIPA gene is responsible for production of lysosomal acid lipase enzyme and is present in lysosomes, so any mutation in this gene leads to accumulation of cholesteryl esters and triglycerides in hepatocytes. The accumulation of such fatty substance leads to hepatomegaly with progressive liver cirrhosis and fibrosis. This disease is further classified into two types based on the onset form which includes infantile-onset form and later-onset form. The infantile- onset form is also called Wolman disease that results in malnutrition, hepatomegaly and liver disease along with adrenal gland calcification.
Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lysosomal-acid-lipase-deficiency-lal-d-market
On geographical estimation, North America accounts the largest market share due to increasing uptake of Kanuma and increasing cases of LAL-D sufferers. Moreover increasing children population susceptible to influenza infection is another factor driving the market growth. Europe accounts the second largest market share due to availability of funds for research activities related to rare diseases and presence of huge patient’s population. Asia-Pacific is expected to account for the largest market share over coming years for the Lysosomal acid lipase deficiency (LAL-D) market due to the approval for Kanuma and improvement rates in disease diagnosis.
The major players covered in the Lysosomal acid lipase deficiency (LAL-D) market are Alexion Pharmaceuticals, Inc., Pfizer Inc., Morepen, LUPIN, Triveni Interchem Private Limited, Lannett, Hetero Healthcare Limited, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Sandoz International GmbH, BioCrick BioTech, Actiza Pharmaceutical Private Limited, Teva Pharmaceuticals USA, Inc., Glenmark Pharmaceutical Inc., ANGLE BIO PHARMA, Accord Healthcare Limited, AstraZeneca, Prudence Pharma Chem, Novadoz Pharmaceuticals, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Perrigo Company plc among other domestic and global players.
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475